>
Dova Pharmaceuticals Inc logo

DOVA - Dova Pharmaceuticals Inc Share Price

$28.04 0.0  0.0%

Last Trade - 11/11/19

Sector
Healthcare
Size
Micro Cap
Market Cap £n/a
Enterprise Value £n/a
Revenue £9.99m
Position in Universe th / 6848
Bullish
Bearish
Unlock DOVA Revenue
Momentum
Relative Strength (%)
1m -5.07%
3m
6m
1yr
Volume Change (%)
10d / 3m
Price vs... (%)
52w High
50d MA
200d MA
Growth & Value
12m Forecast Rolling Industry Market
Valuation (ttm) Industry Market
Margin of Safety
Qualifying GuruScreens
Financial Summary
Year End 31st Dec 2013 2014 2015 2016 2017 2018 2019E 2020E CAGR / Avg
0.000 0.000 0.000 0.000 0.000 10.4 16.8 51.9
PEG
Profitability
ROA
%
%
Cashflow
Dividends
Balance Sheet
NFA
m
FINANCIAL BRIEF: : For the nine months ended 30 September 2019, DovaPharmaceuticals Inc revenues increased 45% to $10.9M. Netloss increased 3% to $54.7M. Revenues reflect Product sales, net increase of 84% to $9M. Higher net loss reflectsGeneral and administrative -Gross increase of 14% to $41.9M(expense), Interest Exp-Net of Capitalized increase of 52%to $2M (expense), Research and development - increase of 3%to $11.5M (expense).
Health Trend(F-Score)
0 1 2 3 4 5 6 7 8 9
Bankruptcy Score(Z-Score)
Distress
Cautious
Safe
Earnings Manipulation Risk(M-Score)
Other Ratios
Recent History
Latest interim period vs. prior period Industry Market
3yr Compound Annual Growth Rate Industry Market
Graphical History

Revenue

DOVA Revenue Unlock DOVA Revenue

Net Income

DOVA Net Income Unlock DOVA Revenue

Normalised EPS

DOVA Normalised EPS Unlock DOVA Revenue

PE Ratio Range

DOVA PE Ratio Range Unlock DOVA Revenue

Dividend Yield Range

DOVA Dividend Yield Range Unlock DOVA Revenue
Analyst Forecasts
Price Target:
( below Price)
31st Dec 2021
31st Dec 2022
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change
Analyst Consensus
Strong Sell Sell Hold Buy Strong Buy
EPS 2020 /  2021
DOVA EPS Forecasts Unlock DOVA Revenue
Profile Summary

Dova Pharmaceuticals, Inc. is a clinical-stage pharmaceutical company. The Company is focused on acquiring, developing and commercializing drug candidates. The Company’s initial focus is on thrombocytopenia, a disorder characterized by a low blood platelet count. The Company is developing avatrombopag for treatment of thrombocytopenia in patients with chronic liver disease (CLD). The Company’s product candidate, avatrombopag is an orally administered thrombopoietin receptor agonist, or TPO-RA. The Company has completed pivotal Phase 3 clinical trials that evaluated avatrombopag for the treatment of thrombocytopenia in patients with CLD. The Company has not generated any revenue.

Directors
Last Annual December 31st, 2018
Last Interim September 30th, 2019
Incorporated March 24, 2016
Public Since June 29, 2017
No. of Shareholders: 12
No. of Employees: 115
Sector Healthcare
Industry Biotechnology & Medical Research
Index
Exchange NASDAQ Global Market
Shares in Issue 28,821,405
Free Float (0.0%)
Eligible for
ISAs
SIPPs
DOVA Share Price Performance
Share Price
Bid - Ask
Low - High
Spread
Day's Change
Avg Volume
Open - Close
Range (12m)
Beta
Latest News for DOVA
Upcoming Events for DOVA
Frequently Asked Questions for Dova Pharmaceuticals Inc
What is the Dova Pharmaceuticals Inc share price?

As of 11/11/19, shares in Dova Pharmaceuticals Inc are trading at $28.04, giving the company a market capitalisation of £n/a. This share price information is delayed by 15 minutes.

How has the Dova Pharmaceuticals Inc share price performed this year?

Shares in Dova Pharmaceuticals Inc are currently trading at $28.04 and the price has moved by 66.02% over the past 365 days. In terms of relative price strength - which takes into account the overall market trend - the Dova Pharmaceuticals Inc price has moved by 14.46% over the past year.

What are the analyst and broker recommendations for Dova Pharmaceuticals Inc?

Of the analysts with advisory recommendations for Dova Pharmaceuticals Inc, there are there are currently 1 "buy" , 3 "hold" and 0 "sell" recommendations. The overall consensus recommendation for Dova Pharmaceuticals Inc is Hold. You can view the full broker recommendation list by unlocking its StockReport.

When will Dova Pharmaceuticals Inc next release its financial results?

Dova Pharmaceuticals Inc is scheduled to issue upcoming financial results on the following dates:

Interim results are scheduled for: 2020-09-30
What is the Dova Pharmaceuticals Inc dividend yield?

Dova Pharmaceuticals Inc does not currently pay a dividend.

Does Dova Pharmaceuticals Inc pay a dividend?

Dova Pharmaceuticals Inc does not currently pay a dividend.

When does Dova Pharmaceuticals Inc next pay dividends?

Dova Pharmaceuticals Inc does not currently pay a dividend.

How do I buy Dova Pharmaceuticals Inc shares?

To buy shares in Dova Pharmaceuticals Inc you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.

What is the market cap of Dova Pharmaceuticals Inc?

Shares in Dova Pharmaceuticals Inc are currently trading at $28.04, giving the company a market capitalisation of £n/a.

Where are Dova Pharmaceuticals Inc shares listed? Where are Dova Pharmaceuticals Inc shares listed?

Here are the trading details for Dova Pharmaceuticals Inc:

Country of listing: United States
Exchange: NMQ
Ticker Symbol: DOVA
What kind of share is Dova Pharmaceuticals Inc?

We were not able to load our ranking data for Dova Pharmaceuticals Inc

Is there a Dova Pharmaceuticals Inc share price forecast 2021?

We were not able to load any forecast data for Dova Pharmaceuticals Inc.

How can I tell whether the Dova Pharmaceuticals Inc share price will go up?

An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Dova Pharmaceuticals Inc. Over the past six months, the relative strength of its shares against the market has been 0.105k%. At the current price of $28.04, shares in Dova Pharmaceuticals Inc are trading at % against their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.

What is the Dova Pharmaceuticals Inc PE Ratio?

We were not able to find PE ratio data for Dova Pharmaceuticals Inc.

Who are the key directors of Dova Pharmaceuticals Inc?

We were unable to find the directors for Dova Pharmaceuticals Inc.

Who are the major shareholders of Dova Pharmaceuticals Inc?

Here are the top five shareholders of Dova Pharmaceuticals Inc based on the size of their shareholding:

Similar to DOVA
© Stockopedia 2021, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.